Delivery Order SPE2DB22D2009-SPE2DB24FM1QL

Award Date 8/25/24
Potential Completion Date 8/26/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,936.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 12,000 unit capsules of the drug CREON DR, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp also holds a significant Indefinite...
This federal contract award, valued at $1,445.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract involves the delivery of 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE UU 100S. The award is a Firm Fixed Price Delivery Order with a completion date of September 20, 2024. This contract award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, valued at $1,758.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract is for the delivery of 12,000 unit capsules of the drug CREON DR, a prescription medication. This award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and provides a wide range of pharmaceutical...
This federal contract award, valued at $1,226.88, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 36,000 unit capsules of the medication CREON DR, with a period of performance through May 12, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $5,562.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 unit capsules of the drug CREON DR, which is used to treat various medical conditions. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $4,367.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 36,000 unit capsules of the medication CREON DR, with an ultimate completion date of April 18, 2025. This contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,456.35, is for the delivery of 36,000 unit capsules of the product "CREON DR" to support federal healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of May 9, 2024. The contract award was not set aside for any specific...
This federal contract award, valued at $8,724.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 unit capsules of the product "CREON DR" and has a completion date of March 12, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 36,000 units of the pharmaceutical product CREON DR capsules, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,818.18 firm fixed-price delivery order has a completion date of February 24, 2025 and was awarded on February 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,961.70 firm fixed price delivery order is for the supply of 24,000 unit capsules of the medication Creon DR. The contract has an ultimate completion date of October 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM1QL
    Delivery Order

This federal contract award, valued at $1,983.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 36,000 unit capsules of the medication CREON DR. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is August 26, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to supply a wide range of pharmaceutical products and medical supplies to support government healthcare programs, including those serving military personnel, veterans, and other federal beneficiaries.

Generated 11/24/24, 9:23 AM